Publications

Out-of-Pocket(OOP) Expenditure for Prescription Drugs among South Korean Outpatients under the National Health Insurance System: Focus on Chronic Diseases Including Diabetes

Full metadata record

DC Field Value
dc.contributor.authorHyun Soon Sohn
dc.contributor.authorJin-Won Kwon
dc.contributor.authorPark, Eun-Ja
dc.date.accessioned2017-01-25T04:11:07Z
dc.date.available2017-01-25T04:11:07Z
dc.date.issued2012-06-28
dc.identifier.issn2155-6156
dc.identifier.urihttps://repository.kihasa.re.kr/handle/201002/25138
dc.description.abstractAbstract Introduction: There is substantial concern about the increasing number of obese children and adolescents, resulting in continuing risks for chronic conditions such as diabetes. This study was aimed at estimating the annual expense of out-of-pocket prescription drugs (OOP-PD) attributable to chronic diseases in adult outpatients in South Korea. Method: Korea Health Panel Survey (KHPS) data from 2008–2009 were used. Chronic diseases such as diabetes, hypertension, asthma and osteoarthritis were included in analyzing OOP-PD expenses. The annual OOPPD expenses were defined as total amount paid per person during one year in 2008, for prescription drugs not listed in the national formulary and the legal copayment portion (30%) for formulary-listed prescription drugs in outpatient settings. Relationship of chronic diseases to OOP-PD expenses was analyzed using a generalized linear model with a log link function. Result: A total of 12,082 subjects were analyzed. Subjects having three or more chronic diseases showed OOP-PD values that were 5-times higher than those without any chronic diseases. Diabetes was the chronic disease contributing the most to OOP-PD expenses. The cost ratio (CR) in diabetic subjects without concurrent chronic diseases (i.e., hypertension, osteoarthritis, and asthma) was 6.1 as compared to those without chronic diseases, followed by subjects with asthma (CR = 4.7), hypertension (CR = 4.0), two or more concurrent chronic diseases but no diabetes (CR = 4.2), and osteoarthritis (CR = 2.0). Conclusion: High OOP-PD values serve as a proxy for the total healthcare expenditure in patients with chronic disease, especially diabetes. These costs might encourage accelerated prevention programs among populations at higher risks in South Korea public health point of view, as in many countries encountering budget constraints in recent years.
dc.format.extent6
dc.languageeng
dc.publisherDiabetes & Metabolism
dc.titleOut-of-Pocket(OOP) Expenditure for Prescription Drugs among South Korean Outpatients under the National Health Insurance System: Focus on Chronic Diseases Including Diabetes
dc.typeArticle
dc.type.localArticle(Academic)
dc.identifier.apprname학술논문평가
dc.subject.keywordKorea health panel survey
dc.subject.keywordOut-of-pocket expense
dc.subject.keywordPrescription drug
dc.subject.keywordChronic
dc.subject.keyworddiseases
dc.subject.keywordDiabetes
dc.contributor.affiliatedAuthor박은자
dc.citation.titleJournal Diabetes Metab
dc.citation.volume3
dc.citation.number5
dc.citation.startPage1
dc.citation.endPage6
dc.identifier.bibliographicCitationJournal Diabetes Metab, vol. 3, no. 5, pp. 1 - 6
메타데이터 간략히 보기

공유

qrcode
공유하기
Cited 2 time in

아이템 조회 수, 다운로드 수

Loading...

라이선스

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.